They found that in tissue the CADM1/MAL combination was superior to discriminate each, CIN3 and cervical cancer from normal tissue/CIN1 with methylation-positivity rates of 97% (CIN3) and 99% (cervical cancer). This evidence concerns the gene MAL and cervical cancer.